Project Farma (PF)’s Post

Now Available On Demand Here: https://lnkd.in/eDyhJn_G Did you miss our panel discussion, 'The Future of Cell Therapy Development and Delivery'? It's now available on demand! Listen as industry experts John Khoury, Christopher McDonald, Jason C. Foster, Mark Frattini, Philip Cyr and Andy Kinley, PhD discuss cutting-edge technologies, manufacturing strategies, and evolving regulations in the cell therapy space. #celltherapy #ctxdelivery #precisionmedicine Endpoints News

With only a few weeks to go until the 7th CAR-TCR Summit Europe, we caught up with Ali Mohamed, PhD, Senior Vice President of CMC and Immatics to gain some early insights! View the full interview now: https://ter.li/ni8c62 Discover Ali's thoughts on: 🚧 What are the major hurdles that remain in cell therapy manufacturing? 🚀 Why are next-gen advances so important in the cell therapy space? 🎢 How can platforms like this help address these challenges and accelerate next gen advances? #CARTCR

Watch the latest episode of 'Pioneers and visionaries of cell therapy' to hear Florence Mousty, Julien Camisani, and others share the story of how Cytiva's Sepax technology influenced CAR T: https://lnkd.in/eiUJZda2 #CART #celltherapy

Dive into the dynamic world of cell therapy with the release of the first part of our 2023 Landscape Review Series! Uncover the latest trends, challenges, and innovations that shaped the drug landscape.  Download your copy now! https://ter.li/rzt2xj #CellTherapy #LandscapeReview

Watch the latest episode of 'Pioneers and visionaries of cell therapy' to hear Florence Mousty, Julien Camisani, and others share the story of how Cytiva's Sepax technology influenced CAR T: https://lnkd.in/eZgQ2npk #CART #celltherapy

What are the four major pain points in cell therapy manufacturing scale-up? In this clip, Dawn Maier from ElevateBio identifies one — labor costs. Watch the full episode to learn about the others. https://lnkd.in/dmU7cTAd

What are the four major pain points in cell therapy manufacturing scale-up? In this clip, Dawn Maier from ElevateBio identifies one — labor costs. Watch the full episode to learn about the others. https://lnkd.in/eZ8d3Gun

What are the four major pain points in cell therapy manufacturing scale-up? In this clip, Dawn Maier from ElevateBio identifies one — labor costs. Watch the full episode to learn about the others. https://lnkd.in/eAgJhEb9

Why is it challenging to bring cell therapies to patients? In this clip, Dawn Maier from ElevateBio calls out one big reason — talent. The latest episode of our 'Pioneers and visionaries of cell therapy' series examines how we overcome four key barriers. Watch it here. https://lnkd.in/eujwSHbs #celltherapy #CART

#Interview now available! Tracking current and predicting future cell therapy #analyticaltoolkit evolution With #celltherapy technologies and modalities entering the clinic and the marketplace, the industry’s focus remains fixed on delivering an analytical toolkit capable of adequately characterizing these novel products. In this article, Namyong Kim (CEO, Curiox Biosystems) explores technological breakthroughs that could deliver the requisite improvements in speed, accuracy, consistency, and sensitivity. Read below: